Business ❯Pharmaceuticals

Biotechnology

Drug Development mRNA Technology Prevacus Vaccine Development BioNTech Regulatory Approval Market Impact Diagnostics Royalty Agreements Medical Products Active Ingredients Amylyx Pharmaceuticals, Inc. Clinical Trials Biopharmaceutical Companies Acquisitions Mergers and Acquisitions Moderna

AstraZeneca Acquires Belgian Biotech EsoBiotec in $1 Billion Deal

The acquisition aims to advance in vivo cell therapies, promising faster and more accessible cancer treatments through innovative technology.

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

BioNTech Settles COVID-19 Vaccine Royalty Disputes for $1.2 Billion

Roche Begins Construction on €600 Million Diagnostic Production Center in Bavaria

Monte Rosa Therapeutics' Stock Soars After $2.1 Billion Deal with Novartis

Rwanda Battles Deadly Marburg Virus Outbreak

Health Canada Approves Moderna's Updated COVID-19 Vaccine

Moderna to Cut $1.1 Billion in R&D Spending as Vaccine Sales Decline

GSK Acquires CureVac's mRNA Vaccines for COVID-19, Flu

Vertex Acquires Alpine Immune Sciences for $4.9 Billion to Expand Kidney Disease Treatment Portfolio

Amylyx Pharmaceuticals Faces Multiple Class Action Lawsuits